Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Dec 14 2018

Full Issue

Genetic Tests That Use Multiple Variants To Predict Disease Risk Are Gaining Popularity. But Are They Reliable?

The tests are expanded versions of ones that look at a single DNA mutation to assess the risk of getting common diseases. But many questions still remain, including what to even do with the results if a patient is found to be at higher risk. In other public health news: abortion access, gene-editing, lead in toys, and bullying.

Stat: What's A Polygenic Risk Score And How Good Is It At Predicting Disease? 

The commercial landscape for genetic testing has come a long way from testing only for certain inherited genes directly linked to disease, such as BRCA genes whose mutations heighten risk for breast cancer. Myriad Genetics made its name with BRCA testing, but in 2017 the company also began marketing a different type of test, one that turns up multiple genetic variants found throughout a woman’s genome that together may point toward her risk of breast cancer. Earlier this year Ambry Genetics began marketing a similar test to estimate a man’s risk of prostate cancer. (Robbins, Garde and Feuerstein, 12/14)

CNN: Restricting Abortion Access

Access to abortion services is a contentious issue in the United States. Clinics in many states are at risk of shutting down and operate with heightened security. Doctors can be hard to find in states with restrictive laws around abortion clinics, so some doctors travel in from out of state to provide care. (12/11)

NPR: Standards Needed For Editing Of Human Germline

Three of the most influential scientific organizations in the world are calling for an urgent international effort to prevent scientists from creating any more gene-edited babies without proper approval and supervision. Global standards are needed quickly to ensure gene-editing of human embryos moves ahead safely and ethically, according to the presidents of the U.S. National Academy of Medicine, U.S. National Academy of Sciences and the Chinese Academy of Sciences. (Stein, 12/13)

Reuters: New York Sues Target, Walmart Over Lead-Contaminated Toys

Target Corp, Walmart Inc and toy importer LaRose Industries were sued on Thursday over the sale of lead-contaminated children's toys, New York Attorney General Barbara Underwood said. The lawsuit, filed in New York state court in Albany, is over "Cra-Z-Jewelz" jewelry-making kits that were imported by LaRose and sold by Target and Walmart. Tests conducted by the attorney general's office found that the kits contained levels of lead that were up to 10 times higher than the federal limit, according to the complaint. (12/13)

The Associated Press: First Lady Spreads Anti-Bullying Message At Kids' Hospital

Melania Trump spread her anti-bullying message on an annual Christmas season visit to a Washington children's hospital on Thursday, reading a story about a Christmas ornament named Oliver who is bullied by other ornaments in a family's collection. "Wishing you a Merry Christmas and a happy and healthy new year," the first lady said after she finished reading "Oliver the Ornament" at Children's National Health System. The author, Todd Zimmerman, sat a few feet away. (Superville, 12/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF